Department of Defense Adds Lipogems to Their Arsenal

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Musculoskeletal injuries pose the greatest public health problem facing military service members during peacetime and combat. Musculoskeletal issues impact approximately 800,000 service members annually and are the greatest threat to military readiness and the primary reason for medical discharge.

The company Lipogems, is a leading global medical technology company. Today they announced that, through its partnership with Buffalo Supply, Inc., the Lipogems Sports Medicine System is now available within the U.S. Department of Defense (DoD) to help over 2.3 million service members that may be suffering from orthopaedic and wound issues.  Lipogems is a premier FDA cleared medical technology that uses the patient’s own adipose tissue (fat) and injects it into troubled areas to support the repair and healing of injured or damaged tissue.  The simple, minimally invasive procedure uses only a local anesthetic and can be performed in the clinic, on the field, or added to surgery. For veterans with multiple issues, the fat from one harvest can be used in multiple areas in the same setting. Through the Distribution And Pricing Agreement (DAPA), Lipogems is now available at over 60 hospitals and over 400 clinics, and 2 hospital ships (USNS Mercy, USNS Comfort).

“We are proud and honored to be helping our nation’s brave active military and veterans. Currently, Lipogems is being used by military physicians with great success to help those that have tried conservative options with limited relief for their orthopaedic issues and are not ready for major invasive surgery. DAPA provides better access to the DoD medical facilities and efficient means of supporting the military for their orthopaedic, wound, and burn issues. As a responsible company, Lipogems is supported by strong scientific and clinical evidence with over 70+publications in peer-reviewed journals from leading institutions from around the world. We would like to recognize and thank the Geneva Foundation for the MIRROR Study evaluating Lipogems for knee issues in active military patients and Brooke Army Medical Center for evaluating Lipogems for wound victims. Also, we would like to thank the multiple orthopaedic physicians that have donated the Lipogems procedure to retired Special Operations, veterans, and active military. Our veterans deserve the best access to healthcare and we are proud to help the heroic men and women who serve our country.” Said Carl Llewellyn, CEO, and President of Lipogems USA. Additional information available here.






Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.